Fusen Pharmaceutical Co., Ltd. (HK:1652) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Fusen Pharmaceutical Co., Ltd. successfully held its Annual General Meeting (AGM) on May 28, 2024, where all proposed resolutions were overwhelmingly approved by shareholders. Key resolutions included the adoption of audited financial statements, re-election of directors, and the re-appointment of KPMG as auditors. Shareholders also granted the directors general mandates to manage share issuances and repurchases, indicating strong investor support for the company’s governance.
For further insights into HK:1652 stock, check out TipRanks’ Stock Analysis page.